Fresenius SE & Co. KGaA is a German multinational health care company based in Bad Homburg vor der Höhe.

The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.

[10][non-primary source needed] The company changed its legal status once again on 28 January 2011, becoming a Kommanditgesellschaft auf Aktien (KGaA - German partnership limited by shares) with a Societas Europaea as a partner with unlimited liability (SE & Co.

[18] In November 2014, the company announced that its Russian partners, Sistema and Zenitco Finance Management, agreed to terminate their joint venture agreement that had been established in April 2014.

[23][non-primary source needed] In February 2019, Fresenius Medical Care acquired NxStage, a US-based maker of in-home dialysis devices, for $2 billion.

[24][non-primary source needed][25] Fresenius Kabi is a supplier of 0.9% sodium chloride Injection USP diluent for use with the Pfizer–BioNTech COVID-19 vaccine.

[27] Fresenius Kabi, which makes the product, threatened legal action against the main author, Danish scientist Anders Perner.

[29][30] In 2019, the company paid $231 million to the United States Department of Justice to settle allegations of civil bribery to obtain business in Angola, Saudi Arabia, Morocco, and Spain.

[31] In January 2020, the Süddeutsche Zeitung reported on tricks used by the health care group Fresenius, according to a case study by the Steuerjustigkeit network.